473924-09-3

Basic information

• Product Name: 4-Hepten-3-one, 4-chloro-5-hydroxy-1-(phenylmethoxy)-, (4E)-
• CAS NO: 473924-09-3
• Molecular Formula: C14H17ClO3
• Molecular Weight: 268.74
• Mol File: 473924-09-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 4-Hepten-3-one, 4-chloro-5-hydroxy-1-(phenylmethoxy)-, (4E)-(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Hepten-3-one, 4-chloro-5-hydroxy-1-(phenylmethoxy)-, (4E)-(473924-09-3)
• EPA Substance Registry System: 4-Hepten-3-one, 4-chloro-5-hydroxy-1-(phenylmethoxy)-, (4E)-(473924-09-3)

Safety Data

• Hazardous Substances Data: 473924-09-3(Hazardous Substances Data)

Upstream product

• 473924-08-2 (4Z)-1-(benzyloxy)-5-hydroxy-4-hepten-3-one 

Downstream Products

• 473924-11-7 5-({(1E)-1-[3-(benzyloxy)propanoyl]-2-hydroxy-1-butenyl}oxy)isophthalonitrile 

Relevant articles and documents

Pyrazole derivatives

This invention relates to pyrazole derivatives of formula (I) or pharmaceutically acceptable salts, solvates or derivative thereof, wherein R1 to R4 are defined in the description, and to processes for the preparation thereof, intermediates used in their preparation of, compositions containing them and the uses of such derivatives. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof. As such the compounds of the present invention are useful in the treatment of a variety of disorders including those in which the inhibition of reverse transcriptase is implicated. Disorders of interest include those caused by Human Immunodificiency Virus (HIV) and genetically related retroviruses, such as Acquired Immune Deficiency Syndrome (AIDS).

Pyrazole derivatives

This invention relates to pyrazole derivatives of formula (I) or pharmaceutically acceptable salts, solvates or derivatives thereof, and to processes for the preparation thereof, intermediates used in their preparation of, compositions containing them and the uses of such derivatives. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof. As such, the compounds of the present invention are useful in the treatment of a variety of disorders including those in which the inhibition of reverse transcriptase is implicated. Disorders of interest include those caused by Human Immunodificiency Virus (HIV) and genetically related retroviruses, such as Acquired Immune Deficiency Syndrome (AIDS).